Introduction: Neurodegenerative disorders, such as Alzheimer’s Disease (AD), continue to present a major economic, social and healthcare burden. These diseases…
Read More
Cognetivity’s Chief Scientific Officer and Co-Founder, Dr. Seyed-Mahdi Khaligh-Razavi will presented results detailing the ICA platform’s ability to detect subtle changes…
New Research Provides Further Scientific Validation of the ICA Test’s Unique Capabilities in Early Stage Detection of Alzheimer’s Disease ICA…
Smart technologies will one day transform the detection, care and treatment of dementia, says Thomas Sawyer. He looks at what…
VANCOUVER, May 2, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB:1UB; OTCQB: CGNSF) announced today the appointment of…
